1

Therapeutically targeting type I interferon directly to XCR1+ dendritic cells reveals the role of cDC1s in anti-drug antibodies

uehvdktkcfgd
Conventional type 1 dendritic cells (cDC1s) are superior in antigen cross-presentation and priming CD8+ T cell anti-tumor immunity and thus. are a target of high interest for cancer immunotherapy. Type I interferon (IFN) is a potent inducer of antigen cross-presentation. but. https://safeersappliancers.shop/product-category/aeg-bpe642020m-mastery-a-rated-built-in-electric-single-oven-wh/
Report this page

Comments

    HTML is allowed

Who Upvoted this Story